| EDGE Shares Outstanding History Table | ||||||||||||||||||||||||||||||||
Below is a table of the EDGE shares outstanding history going back to 10/1/2015:
Also see: EDGE Market Cap History EDGE YTD Return |
As of 2/14/2019 Edge Therapeutics has 31.51 million EDGE shares outstanding. Investors often track the EDGE shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows EDGE share count trends over time, with 15 historical shares outstanding datapoints presented, dating back to 10/1/2015.

| EDGE Shares Outstanding History Table | ||||||||||||||||||||||||||||||||
Below is a table of the EDGE shares outstanding history going back to 10/1/2015:
Also see: EDGE Market Cap History EDGE YTD Return |
| EDGE Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||
EDGE Historical Shares Outstanding: +6.04% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||
| EDGE Stock Price Chart |
| About PDS Biotechnology Corp |
| Edge Therapeutics is a clinical-stage biotechnology company that discovers and develops hospital-based therapies for the management of acute, critical care conditions. Co.'s initial product candidates target rare, acute, neurological and other conditions. EG-1962, Co.'s product candidate, is for the management of aneurysmal subarachnoid hemorrhage, which is bleeding around the brain due to a ruptured brain aneurysm. In addition to EG-1962, Co. is developing EG-1964, as a prophylactic treatment in the management of chronic subdural hematoma, to prevent recurrent bleeding on the surface of the brain. Co. is also developing EG-1965, for the prevention of post-operative atrial fibrillation. We show 15 historical shares outstanding datapoints in our coverage of EDGE's shares outstanding history. Understanding the changing numbers of EDGE shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like EDGE versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching EDGE by allowing them to research EDGE shares outstanding history as well as any other stock in our coverage universe. |
| EDGE Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: Shares Outstanding Importance | |
|
| EDGE Share Performance |
| Shares Outstanding Peers |
| Edge Therapeutics (EDGE) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
EDIT Shares Outstanding History EGLT Shares Outstanding History EGRX Shares Outstanding History EHAB Shares Outstanding History EHC Shares Outstanding History EIDX Shares Outstanding History EIGR Shares Outstanding History EKSO Shares Outstanding History ELAB Shares Outstanding History ELAN Shares Outstanding History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.